Top Stock Movers Nov 17, 2026: Why SLS, GP, FRTT Surged
The biggest stock gainers at the Nov 17, 2026 close: SELLAS, GreenPower, Fort Technology, Mega Matrix and Aytu. Here is why each moved and what the charts show.
SLS — SELLAS Life Sciences Group, Inc. (+156.6%)
SELLAS Life Sciences surged 156.6% to close at $19.16 on 86.3 million shares. That is about 7.5 times its 20-day average of 11.4 million. The stock gapped up 222.7% at the open. A gap is when a stock opens far from the prior close. Market cap was about $1.5 billion.
Why it moved: SELLAS said in a 7:00 AM ET press release that its Phase 3 REGAL trial of the cancer vaccine galinpepimut-S (GPS) in acute myeloid leukemia met its primary overall-survival endpoint. The company reported a 41% reduction in risk of death (hazard ratio 0.59, p=0.035). Median survival was 24.0 months versus 14.7 months for the best available treatment. It plans to meet the FDA and prepare a Biologics License Application. Secondary analyses are still underway.
After the close, SELLAS announced a proposed $150.0 million underwritten public offering, with a 30-day option for up to $22.5 million more. The offering did not cause the rally, but it dilutes existing shareholders. One secondary report said shares fell about 13% after hours. Intraday reports of the gain varied widely, so the closing figure is the one to rely on.
Technical picture: SLS closed at a 52-week high with RSI at 77, ADX at 29 and a bullish moving-average stack. Its relative strength rating was 99 and its trend-template score was 8. Conviction was only 4/100 (grade D), since a one-day vertical move is not an established pattern. Free float was 98.7% and short-volume was 69%. The smart-money score was 27/100, with a largest disclosed stake of 7.9%. Reddit chatter jumped to #3 on r/all-stocks.
GP — GREENPOWER MOTOR Co INC. (+87.2%)
GreenPower Motor closed up 87.2% at $2.64 on 68.8 million shares, versus a 20-day average of 12.2 million. It gapped up 92.2%. Market cap was only about $7.1 million, which makes the stock very thin and volatile.
Why it moved: The likely driver was its fiscal second-quarter results. Benzinga reported the shares rose about 73% to $2.44 after those results. The company filed unaudited interim statements for the six months ended September 30, 2026 on a Form 6-K. Sources disagree on the release date, and quoted prices differ across sites, so the exact move size is uncertain. No deal, offering or analyst action dated November 17 turned up.
The backdrop is shaky. One report cited a 1-for-5 reverse split and a Nasdaq minimum-bid notice. Another noted a lender covenant default and just $391K in cash.
Technical picture: GP is still 71.3% below its 52-week high. RSI was 69 and ADX 43, but the moving-average stack was mixed. Relative strength was 9, trend-template 2, and conviction 4/100 (grade D). Free float was 76.8% and short-volume 38%. A bounce like this in a distressed micro-cap carries heavy risk.
FRTT — Fort Technology Inc (+75.6%)
Fort Technology closed up 75.6% at $0.67 on 322 million shares. That is about 20 times its 20-day average of 16.4 million. It gapped up 50.6%.
Why it moved: No single confirmed catalyst is established, but headlines point to its Q3 report. Quantisnow cited record nine-month revenue of $11.981 million, up 49%, and GuruFocus cited 48% revenue growth alongside a Nasdaq price deficiency notice. Kalkine mentioned a USD 20 million note program in the background. A 6-K was filed November 16.
Technical picture: A morning star candle appeared, a three-candle pattern that can signal a reversal. RSI was 59 and ADX 25. The stock is still 83.7% below its 52-week high. Conviction was 40/100 (grade D). Free float was just 22.1%, so few shares trade freely. Short-volume was 22%. One 13D/G holder owns 72.5%, and the smart-money score was 34/100. Low float and a sub-$1 price mean sharp swings in both directions.
MPU — Mega Matrix Inc (+55.5%)
Mega Matrix closed up 55.5% at $1.99 on 150.9 million shares, about 20 times its 20-day average of 7.55 million. It gapped up 18.0%. Market cap was about $87.0 million.
Why it moved: No news, filing or announcement explains the move. The only same-day headline noted the stock's rise and an overbought hourly RSI of 75.86. This looks momentum-driven. Free float was 93.7% and short-volume was 44%, so this was not a low-float squeeze.
Technical picture: The trend remains weak. The moving-average stack was bearish, and the stock is 91.1% below its 52-week high. Relative strength was 4 and trend-template 1. RSI was 58, ADX 18, and conviction 40/100 (grade D). Unexplained spikes like this often fade.
AYTU — AYTU BIOPHARMA, INC (+45.9%)
Aytu BioPharma closed up 45.9% at $2.65 on 810.7 million shares, about 20 times its 20-day average of 40.6 million. It gapped up 46.2%. Market cap was about $19.3 million.
Why it moved: Aytu agreed on November 16 to be acquired by Rosemont Pharmaceuticals in a two-step, all-cash tender offer at $2.70 per share, a 51.7% premium to the November 13 close. Benzinga put the fully diluted deal value near $56 million, with unanimous board approval. The deal terms come from secondary outlets, and the tender offer had not yet begun. Closing is expected by the end of 2026. A Maxim Group downgrade to Hold was a minor same-day item.
Because the price sits just under the $2.70 offer, upside looks capped by the deal terms. Deal risk remains if the tender falls through. You can see how the stock was flagged in our after-hours recap from Nov 16.
Technical picture: The lane was "breaking," though the chart pattern was a downtrend. RSI was 79, ADX 23, and the stack mixed. The stock is 13.4% below its 52-week high. Relative strength was 89, conviction 21/100 (grade D). Free float was 67.1% and short-volume 54%.
The bottom line
Today's biggest gainers were driven by a trial result, earnings, a buyout and, in one case, no clear reason. Chasing extended one-day gainers is high-risk. Many give back much of the move, and dilution, such as SELLAS's offering, can hit quickly. Patterns and squeezes fail often, so manage risk and do your own research. This is educational, not financial advice.
StockSetups scans the full US universe after every close and every premarket morning. Compare with yesterday's top movers.
Frequently asked questions
Why is SLS up today?
SELLAS said its Phase 3 REGAL trial of galinpepimut-S in acute myeloid leukemia met its primary overall-survival endpoint, with a hazard ratio of 0.59. The stock closed up 156.6% at $19.16.
Why is AYTU up today?
Aytu agreed to be acquired by Rosemont Pharmaceuticals in an all-cash tender offer at $2.70 per share. The stock closed at $2.65, just under the offer price.
What is a low-float stock?
A low-float stock has few shares available to trade. Heavy demand can move the price sharply in either direction.
Should I buy stocks after a big one-day gain?
Big gainers are volatile and often give back gains, and dilution can follow. This article is educational, not advice, so do your own research.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy